SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-20-020574
Filing Date
2020-05-04
Accepted
2020-05-01 19:06:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 sndx-424b5.htm 424B5 1114246
2 GRAPHIC g5enswc3efi2000002.jpg GRAPHIC 43435
3 GRAPHIC g5enswc3efi2000001.jpg GRAPHIC 3696
4 GRAPHIC g5enswc3efi2000005.jpg GRAPHIC 4100
5 GRAPHIC g5enswc3efi2000004.jpg GRAPHIC 36739
6 GRAPHIC g5enswc3efi2000003.jpg GRAPHIC 4706
  Complete submission text file 0001564590-20-020574.txt   1243631
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233564 | Film No.: 20842274
SIC: 2834 Pharmaceutical Preparations